My Recent Searches
- No Recent Search.
My Tests Viewed
- No Test Viewed.
Cystic Fibrosis Complete™ Rare Mutation Analysis, Entire Gene Sequence
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Cystic fibrosis (CF) is the most common recessive lethal genetic disorder affecting primarily Caucasians of Northern European descent, with anincidence of approximately 1 in 3300 births and a carrier rate of 1 in 29. This test analyzes approximately 1000 mutations that account for greater than 98% of disease causing mutations. This test is only appropriate when there is a strong likelihood of cystic fibrosis and the mutation is not detected in the general cystic fibrosis mutation panel and familial mutations are unknown.
Dye-Term Sequencing Reaction • Polymerase Chain Reaction (PCR)
See Laboratory Report
CF Complete™,CF Rare Mutation Analysis,CFTR Gene Sequencing,CF Sequencing,Cystic Fibrosis Entire Gene Sequencing,Cystic Fibrosis Rare Mutation Analysis,Cystic Fibrosis Sequencing,CF Entire Gene Sequencing
To view specimen requirements and codes please Select a regional laboratory.
Not sure which laboratory serves your office? Call us 866-MYQUEST (866-697-8378)
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.